Tiphaine Vidal-Trecan Selected Research

C-Reactive Protein

1/2018

Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tiphaine Vidal-Trecan Research Topics

Disease

2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2018
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 11/2017
2	Melanoma (Melanoma, Malignant) 01/2018 - 11/2017
1	Lymphopenia (Lymphocytopenia) 10/2020
1	COVID-19 10/2020
1	Hypoglycemia (Reactive Hypoglycemia) 04/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020
1	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Ischemia 01/2020
1	Virilism (Virilization) 01/2020
1	Retinal Neovascularization 01/2020
1	Insulin Resistance 01/2018
1	Gout 01/2018

Drug/Important Bio-Agent (IBA)

1	InterferonsIBA 10/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020
1	Exenatide (Byetta)FDA Link 01/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	AntibodiesIBA 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	Uric Acid (Urate)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	Immune Checkpoint InhibitorsIBA 11/2017
1	NivolumabIBA 11/2017

Therapy/Procedure

1	Critical Care (Surgical Intensive Care) 10/2020
1	Therapeutics 01/2020
1	Immunotherapy 01/2018
1	Duration of Therapy 01/2018
1	Punctures 01/2018